Cell Culture: The Market for Media, Sera and Reagents
The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. This Kalorama Information report, Cell Culture; The Market for Media, Sera and Reagents, analyzes the world market for media, sera and reagents and the major trends and drivers. Authored by Anne Anscomb, it is the fifth time Kalorama Information has looked at this market since 2007.
As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. The report contains market size projections, product offerings of major companies, current culture practice trends and company market share. The report focuses on three segments of the cell culture market
Different kinds of cells require different types of media. Serum based media are widely used to grow a broad range of animal cell types and cell lines such as Chinese hamster ovaries (CHO) or murine myeloma cells (NS0) cells. This report provides market size and forecast to 2019 for the following categories of media:
- Animal-Free Media
- Serum-Free Media
- Chemically Defined Media
Serum has traditionally been used as the major supplement to cell culture media. Serum is a complex mix of albumins, growth factors and growth inhibitors. Serum is one of the most important components of cell culture media and serves as a source for amino acids, proteins, vitamins (particularly fat-soluble vitamins such as A, D, E, and K), carbohydrates, lipids, hormones, growth factors, minerals, and trace elements. This report provides market size and forecast to 2019 for the following categories of sera:
- Newborn Calf
- Other Bovine
- Fetal Bovine Serum
- Other Sera
Cultured cells require a sterile environment and a supply of nutrients for growth. An alternative to purchasing prepared defined media, is to purchase reagents and other cell culture components to create an optimum environment for a particular cell line. Biological reagents are an intrinsic component in every research laboratory and research project. This report provides market size and forecast to 2019 for the following categories of reagents:
- Buffers and Salt Solution
- Cytokines and Growth Factors
- Cell Dissociation Reagents
Eleven cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2014. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects. The report discusses key market drivers and restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production. It also discusses late-breaking trends such as 3D cell Culture. In addition, the report reviews the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems. Country Cell Culture Markets
A global report, market estimates for the overall cell culture market are segmented by geography. The report offers the following regions/countries:
- North America
- Rest of Europe
- Rest of World
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.
Companies Profiled in This Report Include:
Advanced Biotechnologies, Inc.
Analytical Biological Services Inc.
Atlanta Biologicals, Inc.
Athena Enzyme Systems
Cell Essentials, Inc.
CellGenix Technologie Transfer GmbH
ClonTech Laboratories, inc.
Corning Life Sciences
GE Healthcare Life Sciences
J R Scientific, Inc.
Novozymes Biopharma US Inc
Quality Biological, Inc.
SeraCare Life Sciences, Inc.
Sera Laboratories International Ltd
Stemcell Technologies Inc.
Thermo Fisher Scientific, Inc.